CIK 0001798749
- Emerging growth company
Jade Biosciences, Inc.
Sign in to watch- Ticker
- JBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831377888
- Phone
- +1 781-312-3013
- Business address
- 221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aerovate Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-06 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2023-06-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +650 | $1.74 | $1K | 2,259 |
| 2023-06-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +1,600 | $2.14 | $3K | 3,859 |
| 2023-06-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −2,250 | $16.26 | $37K | 1,609 |
| 2023-06-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −450 | 19,158 | ||
| 2023-06-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −200 | 12,288 | ||
| 2023-06-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −200 | 14,094 | ||
| 2023-06-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −650 | 42,758 | ||
| 2023-06-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −750 | 51,482 | ||
| 2023-05-19 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +65 | $1.74 | $113 | 3,316 |
| 2023-05-19 | Gillies Hunter CHIEF MEDICAL OFFICER | Sale 10b5-1 | −65 | $19.50 | $1K | 3,251 |
| 2023-05-19 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −65 | 18,953 | ||
| 2023-05-17 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +1,090 | $1.74 | $2K | 4,341 |
| 2023-05-17 | Gillies Hunter CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,090 | $19.59 | $21K | 3,251 |
| 2023-05-17 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,090 | 19,018 |
Page 16 of 16 · 315 trades